Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CU-30101 vs Pliaglis for facial fractional laser anesthesia
CTR20230339Phase 3Completed
- Sponsor
- Codexis, Inc.
- Start
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of CU-30101, sponsored by Codexis, Inc.. Started Feb 2023; status: completed.
02
Drugs
CU-30101
Beyond the preview
Go deeper on CTR20230339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230339.